Please sign in to follow a disease.

Human parainfluenza virus type 3

Clinical trials for Human parainfluenza virus type 3 explained in plain language.

Never miss a new study

Get alerted when new Human parainfluenza virus type 3 trials appear

Sign up with your email to follow new studies for Human parainfluenza virus type 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Nasal spray vaccine aims to protect kids from two breathing viruses

Vaccine Completed

This study tested two experimental nasal spray vaccines in 24 children aged 2 to 5 years. The vaccines target two viruses that can cause breathing problems: human metapneumovirus (HMPV) and parainfluenza virus type 3 (HPIV3). The main goal was to see if the vaccines are safe and …

Matched conditions: HUMAN PARAINFLUENZA VIRUS TYPE 3

Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine

Last updated Sep 20, 2026 00:00 UTC

Human parainfluenza virus type 3

Get alerted when new Human parainfluenza virus type 3 trials appear

Nasal spray vaccine aims to protect kids from two breathing viruses